DB
VIVS

Danske Bank’s VivoSim Labs VIVS Stock Holding History

Danske Bank’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$9 – 1595
2025
Q1 		$9 Buy
+4
New +$20 ﹤0.01% 1323

Other funds holding VIVS

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank's VIVS Position: Q2 2025 in Review

Danske Bank sold out of VivoSim Labs (VIVS) in Q2 2025, closing a stake of 4 shares — an estimated $9 sold.

Danske Bank first reported a position in VIVS in Q1 2025 and held it in 1 quarter. The position peaked at $9 in Q1 2025. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2025.

  • Danske Bank reported no remaining VivoSim Labs position as of Q2 2025 after selling out during the quarter.
  • Danske Bank sold 4 VivoSim Labs shares in Q2 2025, an estimated $9.
  • Danske Bank first reported a position in VivoSim Labs in Q1 2025 and held it in 1 quarter.
  • Danske Bank's VivoSim Labs position peaked at $9 in Q1 2025.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2025.

Based on Danske Bank's 13F filing for Q2 2025, filed 18 Dec 2025.